These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21945758)

  • 1. [Effect of early intervention with rhein on islet function in db/db mice].
    DU H; Shao JQ; Gu P; Wang J; Liu ZH
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1526-9. PubMed ID: 21945758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of glucose tolerance by rhein with restored early-phase insulin secretion in db/db mice.
    Du H; Shao J; Gu P; Lu B; Ye X; Liu Z
    J Endocrinol Invest; 2012 Jun; 35(6):607-12. PubMed ID: 22776972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of rhein treatment on first-phase insulin secretory function in db/db mice].
    Du H; Shao J; Gu P; Lu B; Wang J; Liu Z
    Zhongguo Zhong Yao Za Zhi; 2010 Oct; 35(20):2764-7. PubMed ID: 21246837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Study of Liraglutide and Insulin Glargine on Glycemic Control and Pancreatic β-Cell Function in db/db Mice.
    Li Y; Zheng J; Shen Y; Li W; Liu M; Wang J; Zhu S; Wu M
    Med Sci Monit; 2018 May; 24():3293-3300. PubMed ID: 29777582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhein protects pancreatic β-cells from dynamin-related protein-1-mediated mitochondrial fission and cell apoptosis under hyperglycemia.
    Liu J; Chen Z; Zhang Y; Zhang M; Zhu X; Fan Y; Shi S; Zen K; Liu Z
    Diabetes; 2013 Nov; 62(11):3927-35. PubMed ID: 23919963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes.
    Yoshida S; Tanaka H; Oshima H; Yamazaki T; Yonetoku Y; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Oct; 400(4):745-51. PubMed ID: 20816753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
    Moon H; Chon J; Joo J; Kim D; In J; Lee H; Park J; Choi J
    Diabetes Metab Res Rev; 2013 Jan; 29(1):19-24. PubMed ID: 22936676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The protection of islet β-cells in db/db mice by combination pioglitazone and glucagon like peptide-1 treatment].
    Song LL; Xiao JZ; Yang WY; Zhang M; Liu BB; Pan L
    Zhonghua Nei Ke Za Zhi; 2011 Sep; 50(9):781-4. PubMed ID: 22176969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic β-cell function.
    Yoshida S; Ohishi T; Matsui T; Tanaka H; Oshima H; Yonetoku Y; Shibasaki M
    Diabetes Obes Metab; 2011 Jan; 13(1):34-41. PubMed ID: 21114601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemic effect of aspalathin, a rooibos tea component from Aspalathus linearis, in type 2 diabetic model db/db mice.
    Kawano A; Nakamura H; Hata S; Minakawa M; Miura Y; Yagasaki K
    Phytomedicine; 2009 May; 16(5):437-43. PubMed ID: 19188054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Cell-protective effect of 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid as a glutamate dehydrogenase activator in db/db mice.
    Han SJ; Choi SE; Yi SA; Lee SJ; Kim HJ; Kim DJ; Lee HC; Lee KW; Kang Y
    J Endocrinol; 2012 Mar; 212(3):307-15. PubMed ID: 22131441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats.
    Jahan H; Choudhary MI; Manzoor M; Khan KM; Perveen S; Atta-Ur-Rahman
    Chem Biol Interact; 2017 Aug; 273():237-244. PubMed ID: 28625491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly-GLP-1, a novel long-lasting glucagon-like peptide-1 polymer, ameliorates hyperglycaemia by improving insulin sensitivity and increasing pancreatic beta-cell proliferation.
    Ma X; Hui H; Liu Z; He G; Hu J; Meng J; Guan L; Luo X
    Diabetes Obes Metab; 2009 Oct; 11(10):953-65. PubMed ID: 19531053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ezetimibe on insulin secretion in db/db diabetic mice.
    Zhong Y; Wang J; Gu P; Shao J; Lu B; Jiang S
    Exp Diabetes Res; 2012; 2012():420854. PubMed ID: 23118741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic and Antiobesity Effects of Artemether in db/db Mice.
    Guo Y; Fu W; Xin Y; Bai J; Peng H; Fu L; Liu J; Li L; Ma Y; Jiang H
    Biomed Res Int; 2018; 2018():8639523. PubMed ID: 29862294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Lyn kinase activator MLR-1023 is a novel insulin receptor potentiator that elicits a rapid-onset and durable improvement in glucose homeostasis in animal models of type 2 diabetes.
    Ochman AR; Lipinski CA; Handler JA; Reaume AG; Saporito MS
    J Pharmacol Exp Ther; 2012 Jul; 342(1):23-32. PubMed ID: 22431203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
    Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elovl6 Deficiency Improves Glycemic Control in Diabetic
    Zhao H; Matsuzaka T; Nakano Y; Motomura K; Tang N; Yokoo T; Okajima Y; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
    Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose doxycycline decreases systemic inflammation and improves glycemic control, lipid profiles, and islet morphology and function in db/db mice.
    Wang N; Tian X; Chen Y; Tan HQ; Xie PJ; Chen SJ; Fu YC; Chen YX; Xu WC; Wei CJ
    Sci Rep; 2017 Oct; 7(1):14707. PubMed ID: 29089617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained treatment with a stable long-acting oxyntomodulin analogue improves metabolic control and islet morphology in an experimental model of type 1 diabetes.
    Irwin N; Pathak V; Pathak NM; Gault VA; Flatt PR
    Diabetes Obes Metab; 2015 Sep; 17(9):887-95. PubMed ID: 26095087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.